RedShift BioAnalytics
Latest round
- Series E
Last raised
- Oct 2021
Total raised
- $42M
Investors
- 11
About RedShift BioAnalytics
RedShift BioAnalytics, Inc.Founded in 2005, RedShift BioAnalytics, Inc. is headquartered in Burlington, US. The company specializes in analytical instrumentation for protein therapeutic drugs. The CEO is Julien Bradley.RedShift BioAnalytics specializes in advanced analytical instrumentation designed for the research, development, and manufacturing of protein therapeutic drugs. Their core products include Microfluidic Modulation Spectroscopy (MMS) technology and the HaLCon real-time titer measurement platform, which provides rapid analysis of proteins and biomolecules.RedShift BioAnalytics generates revenue primarily from the sale of its patented analytical instruments and related services to biopharmaceutical companies. The business operates on a B2B model, with direct sales agreements that may include service contracts for ongoing technical support and maintenance of instruments. The company plans to design and launch new products targeting specific biopharmaceutical markets, while expanding its geographic presence in North America, Europe, and Asia by 2023.
Who invested in RedShift BioAnalytics
11 investors across 6 rounds
See all investors in RedShift BioAnalytics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RedShift BioAnalytics
Who invested in RedShift BioAnalytics?
RedShift BioAnalytics has 11 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RedShift BioAnalytics raised?
RedShift BioAnalytics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did RedShift BioAnalytics last raise money?
RedShift BioAnalytics's most recent round on record is a Series E, in Oct 2021.
What does RedShift BioAnalytics do?
RedShift BioAnalytics is a biotechnology company.
Where is RedShift BioAnalytics headquartered?
RedShift BioAnalytics is headquartered in Burlington, US.
Which VCs invest in companies like RedShift BioAnalytics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RedShift BioAnalytics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like RedShift BioAnalytics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.